James M. McKim, Ph.D., DABT
CSO and Founder
Dr. McKim graduated with high honors from the doctoral program in biochemical and molecular toxicology at Oregon State University and trained as a postdoctoral fellow at the University of Kansas Medical School. He is a diplomat of the American Board of Toxicology and has served as President of the Michigan Society of Toxicology.
Dr. McKim has held many positions in his 20 years as a toxicologist. He was Assistant Professor at the University of Colorado School of Medicine where he researched mechanisms underlying liver diseases in children. He was awarded the DowCorning Technical Achievement Award for the research he led as Head of the Biochemical Molecular Toxicology Group on the biological effects of silicone products. At Pharmacia (later Pfizer) he was Director of the Global Center of Excellence for In Vitro Toxicology where he developed and patented algorithms assessing in vivo toxicity risk using in vitro data. Dr. McKim is the Founder and Chief Scientific Officer of CeeTox Inc, a leading CRO in the field of in vitro toxicity screening.
Dr. McKim has published numerous scientific manuscripts, book chapters and reviews, and is a frequently-requested speaker at conferences and events in the US and around the world.